Related Experiment Video
Updated: Mar 14, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
254
Endobronchial Inflammatory Myofibroblastic Tumour-A Case Report
Vishnukanth Govindaraj1, Debasis Gochhait2, Balla Nagamalli Kumar3
1Assistant Professor, Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) , D Nagar, Puducherry, India .
Journal of Clinical and Diagnostic Research : JCDR
|September 23, 2016
Summary
Lung malignancies are increasing, often diagnosed late. This case highlights a rare endobronchial Inflammatory Myofibroblastic Tumour (IMT), emphasizing diagnostic challenges and varied treatment for this uncommon lung condition.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Lung cancer incidence is rising, frequently detected at advanced stages.
- Fiberoptic bronchoscopy is crucial for lung malignancy diagnosis and staging.
- Distinguishing malignant from benign endobronchial lesions remains a clinical challenge.
Observation:
- A rare case of endobronchial Inflammatory Myofibroblastic Tumour (IMT) is presented.
- Inflammatory Myofibroblastic Tumour (IMT) is an uncommon lung neoplasm with debated malignant potential.
- Endobronchial presentation of IMT is exceptionally rare.
Findings:
- The case underscores the diagnostic difficulty of non-malignant endobronchial masses.
- The aetiology of IMT is not fully understood, contributing to management complexity.
- Established treatment protocols for IMT are lacking.
Implications:
- This case highlights the importance of considering rare diagnoses like IMT in endobronchial lesions.
- Further research is needed to clarify the nature and optimal management of IMT.
- Accurate diagnosis is critical for appropriate patient management and prognosis.
